FDA Approves Segluromet (ertugliflozin and metformin hydrochloride) for Type 2 Diabetes. Segluromet is indicated as an adjunct to diet and
Day: December 28, 2017
Macrilen for treating growth hormone deficiency
Macrilen (macimorelin) stimulates the secretion of growth hormone from the pituitary gland into the circulatory system. Stimulated growth hormone levels
Giapreza for treating low blood pressure
FDA Approves Giapreza (angiotensin II) to treat dangerously low blood pressure. Giapreza (angiotensin II) injection for intravenous infusion to increase
Lumify for treating eye redness
Ocular redness is a common condition that can be caused by inflammation of almost any part of the eye. With
Exercise improves memory and thinking
Mild cognitive impairment is an intermediate stage between the expected cognitive decline of normal aging and the more serious decline
DNA test for breast cancer
Scientists have developed a DNA test that may diagnose fatal breast cancer one year earlier than current methods. Changes in
